Fernández J.A. Biology, biotechnology and biomedicine of saffron. Recent Res Dev Plant Sci. 2004;2: 127-159.
Sabzevari. Saffron, the red gold of desert. Agric Bank. 1996;46.
Kafi M, Kakhki AH, Karbasi, A. Saffron (Crocus sativus) production and processing: historical background, economy, acreage, production, yield and uses. Sc Publisher Enfield. 2006; 39-57.
Rios J, Recio M, Giner R, Manez S. An update review of saffron and its active constituents. Phytother Res.1996; 10:189-193.
Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr. 2007;157: 315-319.
Hosseinzadeh H, Nassiri Asl M. Avicenna's (Ibn Sina) the canon of medicine and saffron (Crocus sativus): a review. Phytother Res. 2013; 27:475-83.
Mollazadeh H, Emami SA, Hosseinzadeh H. Razi’s Al-Hawi and saffron (Crocus sativus): a review. Iran J Basic Med Sci.2015;18: 1153–1166.
Khazdair MR, Boskabady MH, Hosseini M, Rezaee R, Tsatsakis AM. The effects of Crocus sativus (saffron) and its constituents on nervous system: A review. Avicenna J Phytomed. 2015;5: 376-391.
Hosseinzadeh H, Ghenaati J. Evaluation of the antitussive effect of stigma and petals of saffron (Crocus sativus) and its components, safranal and crocin in guinea pigs. Fitoterapia. 2006;77: 446-448.
Asdaq SMB, Inamdar MN. Potential of Crocus sativus (saffron) and its constituent, crocin, as hypolipidemic and antioxidant in rats. Appl Biochem Biotechnol.2010;162: 358-372.
Hosseinzadeh H, Khosravan V. Anti-convulsant effects of aqueous and ethanolic extracts of Crocus sativus L stigma in mice. Arch Iran Med. 2002;5: 44-47.
Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L stigma and petal extracts in mice. BMC Pharmacol. 2002;15: 2–7.
Hosseinzadeh H, Karimi G, Niapoor M, editors Antidepressant effect of Crocus sativus L stigma extracts and their constituents, crocin and safranal, in mice. J Med Plants. 2004; 3: 48-58.
Hosseinzadeh H, Noraei NB. Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res. 2009;23: 768-774.
Imenshahidi M, Hosseinzadeh H, Javadpour Y. Hypotensive effect of aqueous saffron extract (Crocus sativus L) and its constituents, safranal and crocin, in normotensive and hypertensive rats. Phytother Res. 2010; 24: 990-994.
Abdullaev F, Espinosa-Aguirre J. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev.2004;28: 426-432.
Hosseinzadeh H, Sadeghnia HR, Ziaee T, Danaee A. Protective effect of aqueous saffron extract (Crocus sativus L) and crocin, its active constituent, on renal ischemia-reperfusion-induced oxidative damage in rats. J Pharm Pharm Sci.2005;8: 387-393.
Hosseinzadeh H, Shamsaie F, Mehri S. Antioxidant activity of aqueous and ethanolic extracts of Crocus sativus L stigma and its bioactive constituents, crocin and safranal. Pharmacogn Mag.2009; 5: 419-424.
Shibamoto T. Retention Indices in Essential Oil Analysis. In: Capillary Gas Chromatography in Essential oil analysis. Edits, Sandra P, and Bicchi C, Dr. Alfred Huethig Verlag, Heidelberg. 1987; 259-274.
Davies NW. Gas Chromatographic Retention Index of Monoterpenes and Sesquiterpenes on Methyl silicone and Carbowax 20 M phases. J Chromatography. 1990; 503:1- 24.
Adams RP, Identification of essential oils by Ion trap Mass Spectroscopy. Academic Press, San Diego, CA. 2017.